agilon health Statistics
Total Valuation
agilon health has a market cap or net worth of $212.85 million. The enterprise value is -$48.32 million.
Important Dates
The last earnings date was Tuesday, November 4, 2025, after market close.
| Earnings Date | Nov 4, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
agilon health has 414.58 million shares outstanding. The number of shares has increased by 1.35% in one year.
| Current Share Class | 414.58M |
| Shares Outstanding | 414.58M |
| Shares Change (YoY) | +1.35% |
| Shares Change (QoQ) | +0.15% |
| Owned by Insiders (%) | 1.60% |
| Owned by Institutions (%) | 60.35% |
| Float | 268.55M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.04 |
| Forward PS | 0.04 |
| PB Ratio | 0.74 |
| P/TBV Ratio | 1.09 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.08, with a Debt / Equity ratio of 0.12.
| Current Ratio | 1.08 |
| Quick Ratio | 1.04 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -56.83 |
Financial Efficiency
Return on equity (ROE) is -73.31% and return on invested capital (ROIC) is -47.99%.
| Return on Equity (ROE) | -73.31% |
| Return on Assets (ROA) | -12.52% |
| Return on Invested Capital (ROIC) | -47.99% |
| Return on Capital Employed (ROCE) | -103.64% |
| Revenue Per Employee | $5.47M |
| Profits Per Employee | -$286,482 |
| Employee Count | 1,076 |
| Asset Turnover | 3.19 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, agilon health has paid $1.68 million in taxes.
| Income Tax | 1.68M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -67.30% in the last 52 weeks. The beta is 0.05, so agilon health's price volatility has been lower than the market average.
| Beta (5Y) | 0.05 |
| 52-Week Price Change | -67.30% |
| 50-Day Moving Average | 0.92 |
| 200-Day Moving Average | 2.35 |
| Relative Strength Index (RSI) | 21.79 |
| Average Volume (20 Days) | 11,242,261 |
Short Selling Information
The latest short interest is 20.88 million, so 5.04% of the outstanding shares have been sold short.
| Short Interest | 20.88M |
| Short Previous Month | 19.79M |
| Short % of Shares Out | 5.04% |
| Short % of Float | 7.78% |
| Short Ratio (days to cover) | 2.99 |
Income Statement
In the last 12 months, agilon health had revenue of $5.89 billion and -$308.26 million in losses. Loss per share was -$0.75.
| Revenue | 5.89B |
| Gross Profit | -107.61M |
| Operating Income | -369.34M |
| Pretax Income | -321.21M |
| Net Income | -308.26M |
| EBITDA | -341.22M |
| EBIT | -369.34M |
| Loss Per Share | -$0.75 |
Full Income StatementBalance Sheet
The company has $310.85 million in cash and $37.12 million in debt, giving a net cash position of $273.73 million or $0.66 per share.
| Cash & Cash Equivalents | 310.85M |
| Total Debt | 37.12M |
| Net Cash | 273.73M |
| Net Cash Per Share | $0.66 |
| Equity (Book Value) | 306.08M |
| Book Value Per Share | 0.74 |
| Working Capital | 98.15M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$68.81 million and capital expenditures -$13.54 million, giving a free cash flow of -$82.35 million.
| Operating Cash Flow | -68.81M |
| Capital Expenditures | -13.54M |
| Free Cash Flow | -82.35M |
| FCF Per Share | -$0.20 |
Full Cash Flow StatementMargins
Gross margin is -1.83%, with operating and profit margins of -6.28% and -5.24%.
| Gross Margin | -1.83% |
| Operating Margin | -6.28% |
| Pretax Margin | -5.46% |
| Profit Margin | -5.24% |
| EBITDA Margin | -5.80% |
| EBIT Margin | -6.28% |
| FCF Margin | n/a |
Dividends & Yields
agilon health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.35% |
| Shareholder Yield | -1.35% |
| Earnings Yield | -136.75% |
| FCF Yield | -36.53% |
Dividend DetailsAnalyst Forecast
The average price target for agilon health is $2.79, which is 443.44% higher than the current price. The consensus rating is "Hold".
| Price Target | $2.79 |
| Price Target Difference | 443.44% |
| Analyst Consensus | Hold |
| Analyst Count | 17 |
| Revenue Growth Forecast (5Y) | 9.65% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
agilon health has an Altman Z-Score of 1.93 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.93 |
| Piotroski F-Score | 2 |
